145 related articles for article (PubMed ID: 28866166)
1. Polymer brush hexadecyltrimethylammonium bromide (CTAB) modified poly (propylene-g-styrene sulphonic acid) fiber (ZB-1): CTAB/ZB-1 as a promising strategy for improving the dissolution and physical stability of poorly water-soluble drugs.
Cao J; Yang B; Wang Y; Wei C; Wang H; Li S
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():282-295. PubMed ID: 28866166
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
3. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
4. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
5. Electrostatic molecular effect of differently charged surfactants on the solubilization capacity and physicochemical properties of salt-caged nanosuspensions containing pH-dependent and poorly water-soluble rebamipide.
Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Lee BJ
Int J Pharm; 2022 May; 619():121686. PubMed ID: 35314274
[TBL] [Abstract][Full Text] [Related]
6. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
Park SH; Choi HK
Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892
[TBL] [Abstract][Full Text] [Related]
7. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
8. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
9. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
[TBL] [Abstract][Full Text] [Related]
10. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
Qian F; Huang J; Hussain MA
J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
[TBL] [Abstract][Full Text] [Related]
11. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
Taupitz T; Dressman JB; Buchanan CM; Klein S
Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
[TBL] [Abstract][Full Text] [Related]
14. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug.
Irwan AW; Berania JE; Liu X
Pharm Dev Technol; 2016 Mar; 21(2):231-8. PubMed ID: 25496001
[TBL] [Abstract][Full Text] [Related]
16. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
17. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
[TBL] [Abstract][Full Text] [Related]
19. The effects of surfactants on the solubility and dissolution profiles of a poorly water-soluble basic drug, carvedilol.
Incecayir T
Pharmazie; 2015 Dec; 70(12):784-90. PubMed ID: 26817275
[TBL] [Abstract][Full Text] [Related]
20. Refining stability and dissolution rate of amorphous drug formulations.
Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]